From: No sign of the tough times coming to an end, first published in August 2007.
Fund manager Gartmore has scuppered plans to wind up Evolutec after its hay fever treatment made from tick saliva failed to do better than a placebo. Read more 'Evolutec'
Call Tinderhouse on +44(0)1227 277832 to help bring your website into line with new AIM rules.
Tinderhouse provides comprehensive investor relations (IR) website solutions that provide all the tools and features needed to satisfy today's regulatory requirements.